T. Rowe Price Investment Management, Inc. - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 96 filers reported holding RAPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.

Quarter-by-quarter ownership
T. Rowe Price Investment Management, Inc. ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,807
-10.5%
1,251,892
+0.7%
0.02%
-6.2%
Q2 2023$23,237
+2.8%
1,242,587
+0.9%
0.02%0.0%
Q1 2023$22,604
-8.5%
1,231,783
-1.3%
0.02%
-15.8%
Q4 2022$24,706
-99.9%
1,247,734
+0.2%
0.02%
-20.8%
Q3 2022$29,947,0001,244,6710.02%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$44,551,92129.58%
GREAT POINT PARTNERS LLC 1,458,070$24,233,1234.41%
Euclidean Capital LLC 1,315,798$21,868,5622.39%
Trustees of Columbia University in the City of New York 73,383$1,219,6252.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 805,828$13,392,8611.54%
Perceptive Advisors 1,920,658$31,921,3361.06%
Deep Track Capital, LP 1,500,000$24,930,0000.96%
Cheyne Capital Management (UK) LLP 20,000$332,4000.96%
Alphabet Inc. 540,270$8,979,2870.58%
BRAIDWELL LP 1,082,512$17,991,3490.57%
View complete list of RAPT THERAPEUTICS INC shareholders